+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hand vein responses to noradrenaline in normotensive patients with insulin-dependent diabetes mellitus and microalbuminuria: effects of alpha-adrenoceptor blockade with doxazosin



Hand vein responses to noradrenaline in normotensive patients with insulin-dependent diabetes mellitus and microalbuminuria: effects of alpha-adrenoceptor blockade with doxazosin



Current Medical Research and Opinion 15(3): 169-176



Nephropathy commonly develops in patients with insulin-dependent (type 1) diabetes. Administration of an antihypertensive agent to type 1 diabetes patients with microalbuminuria, the first clinically detectable stage of nephropathy, can help slow renal deterioration. It is postulated that the exaggerated vasoconstrictor response to noradrenaline seen in these patients may be relevant in the development of microalbuminuria. This open, non-comparative pilot study was designed to investigate the effects of the alpha-adrenoceptor antagonist doxazosin on noradrenaline-induced hand vein vasoconstriction and on albumin excretion in 14 normotensive type 1 diabetes patients with microalbuminuria. After a three-week placebo run-in period, patients received doxazosin (1, 2, and then 4 mg once-daily, at two-week intervals) for six weeks, followed by a two-week placebo washout period. Vasoconstrictor responses to noradrenaline were measured in dorsal hand veins at the end of each two-week period. Hand vein vasoconstrictor responses to noradrenaline decreased significantly, compared with placebo, at 4 mg/day doxazosin (p = 0.006). The mean albumin excretion rate was lower than baseline at all doses of doxazosin, but changes did not reach statistical significance. Doxazosin was generally well-tolerated; four patients (29%) reported mild-to-moderate treatment-related adverse events. This study indicates that alpha 1-adrenoceptor blockade can blunt the exaggerated vascular reactivity to noradrenaline in normotensive type 1 diabetes patients with microalbuminuria, and supports further research into a potential role for doxazosin in preventing the development of diabetic nephropathy.

(PDF emailed within 0-6 h: $19.90)

Accession: 046210968

Download citation: RISBibTeXText

PMID: 10621923

DOI: 10.1185/03007999909114088


Related references

Low prevalence of microalbuminuria in normotensive patients with insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 12(2): 85-90, 1991

Captopril decreases the rate of progression of renal disease in normotensive, insulin-dependent diabetes mellitus patients with microalbuminuria. Journal of the American Society of Nephrology 4(3): 304, 1993

Reduced venous compliance, but normal adrenoceptor activity, in patients with non insulin dependent diabetes mellitus with microalbuminuria. Diabetologia 39(SUPPL 1): A67, 1996

Design and methods for a double-blind, randomized study of tolrestat for the prevention of nephropathy in normotensive patients with insulin-dependent diabetes mellitus and microalbuminuria. Current Therapeutic Research 56(4): 319-332, 1995

Effects of alpha 2-adrenergic blockade on renal hemodynamics in patients with insulin dependent diabetes mellitus. Diabetes Research and Clinical Practice 14(3): 197-203, 1991

Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria. Zhonghua Nei Ke Za Zhi 35(8): 533-536, 1996

Ambulatory blood pressure monitoring and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus. Arquivos Brasileiros de Cardiologia 75(3): 195-204, 2000

Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus. Ugeskrift for Laeger 161(7): 949-952, 1999

Microalbuminuria in long-term insulin-dependent diabetes mellitus. Prevalence and clinical characteristics in a normotensive population. Acta Medica Scandinavica 222(4): 333-338, 1987

Antihypertensive and metabolic effects of doxazosin in hypertensive patients with concomitant non-insulin-dependent diabetes mellitus. Journal of International Medical Research 24(1): 138-146, 1996

Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. Journal of Pediatrics 117(1 Pt 1): 39-45, 1990

Effects of long-term administration of a combined alpha- and beta-adrenoceptor blocking agent on glucose and lipid metabolisms in patients with non-insulin-dependent diabetes mellitus. Journal of International Medical Research 23(2): 106-111, 1995

Effects of lisinopril and metoprolol on microalbuminuria in hypertensive patients with non-insulin-dependent diabetes-mellitus. Nephrology Dialysis Transplantation 9(7): 953-954, 1994

Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 67(5): 1054-1059, 1988

Effects of Terazosin on Glycemic Control, Cholesterol, and Microalbuminuria in Patients with Non--Insulin-Dependent Diabetes Mellitus and Hypertension. American Journal of Therapeutics 3(9): 616-621, 1996